- 专利标题: Manganese-based magnetic resonance contrast agents
-
申请号: US14759114申请日: 2014-01-07
-
公开(公告)号: US09944668B2公开(公告)日: 2018-04-17
- 发明人: Peter Caravan , Eric M. Gale , Galen S. Loving , Shereya Mukherjee , Jiang Zhu
- 申请人: Peter Caravan , Eric M. Gale , Galen S. Loving , Shereya Mukherjee , Jiang Zhu
- 申请人地址: US MA Boston
- 专利权人: The General Hospital Corporation
- 当前专利权人: The General Hospital Corporation
- 当前专利权人地址: US MA Boston
- 代理机构: Fish & Richardson P.C.
- 国际申请: PCT/US2014/010486 WO 20140107
- 国际公布: WO2014/107722 WO 20140710
- 主分类号: A61K49/14
- IPC分类号: A61K49/14 ; A61K49/16 ; C07F13/00 ; A61K49/06 ; A61K51/04 ; A61K49/10 ; A61B5/055 ; A61B5/00
摘要:
Manganese coordination complexes with utility as magnetic resonance probes and as biological reductant sensors are disclosed. In one embodiment, ligands can stabilize both the Mn2+ and Mn3+ oxidation states. In the presence of a reductant such as glutathione, low relaxivity MnIII-HBET is rapidly converted to high relaxivity MnII-HBET with a 3-fold increase in relaxivity, and concomitant increase in magnetic resonance signal. In another embodiment, ligands were designed to chelate Mn(ll) in a thermodynamically stable and kinetically inert fashion while allowing for direct interaction of Mn(ll) with water. In yet another embodiment, high molecular weight multimers containing six Mn(ll) chelators were prepared. The high molecular weight results in slower tumbling of the molecules in solution and can strongly enhance the Mn(ll) relaxivity.
公开/授权文献
- US20150336997A1 MANGANESE-BASED MAGNETIC RESONANCE CONTRAST AGENTS 公开/授权日:2015-11-26
信息查询